ABSTRACT
Background Due to the aging of the population, the prevalence of aortic valve stenosis will increase dramatically in upcoming years. Consequently Transcatheter Aortic Valve Implantation (TAVI) procedures will also expand worldwide. Optimal selection of patients who benefit with improved symptoms and prognosis is key since TAVI is not without risk. Currently we are not able to adequately predict functional outcome after TAVI. Quality of life measurement tools and traditional functional assessment tests do not always agree and can depend on factors unrelated to heart disease. Activity tracking using wearable devices might provide a more comprehensive assessment.
Objectives Identify objective parameters from a wearable device (the Philips Health Watch) associated with improvement after TAVI for severe aortic stenosis.
Methods and results 100 patients undergoing routine TAVI wore a Philips Health Watch for one week before and after the procedure. Watch data were analyzed offline: 97 before and 75 after TAVI. Parameters like the total number of steps and activity time did not change, in contrast to improvements in the six-minute walking test (6MWT) and physical limitation domain of a questionnaire (transformed WHOQOL-BREF).
Conclusions These findings in an elderly TAVI population show that watch-based parameters like the number of steps do not change after TAVI, unlike traditional 6MWT and QoL assessments that do improve. Basic wearable device parameters might be less appropriate for measurement of treatment effects from TAVI.
Competing Interest Statement
HtH is from Philips research; Philips Research provided the health watches used in this study.
Funding Statement
As this is part of the EURValve project which is a European project we received funding from Horizon 2020.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
MEC-U (Netherlands) has approved the submitted work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
FINANCIAL SUPPORT AND RELATIONSHIPS WITH INDUSTRY:
As this is part of the EURValve project which is a European project we received funding from Horizon 2020.
RE reports no additional support or industry relationships.
JMZ reports no additional support or industry relationships.
CC reports no additional support or industry relationships.
MV reports no additional support or industry relationships.
HtH is from Philips research; Philips Research provided the health watches used in this study.
DCJK reports no additional support or industry relationships.
MK reports no additional support or industry relationships.
GA reports no additional support or industry relationships.
TK reports no additional support or industry relationships.
GB reports no additional support or industry relationships.
IW reports no additional support or industry relationships.
PALT reports research grants from Biosensors, ZonMW and opSens
NPJ received internal funding from the Weatherhead PET Center for Preventing and Reversing Atherosclerosis; outside of the current study NPJ and PALT have a pending patent on diagnostic methods for quantifying aortic stenosis and TAVI physiology.
Data Availability
The data that support the findings of this study are available from the corresponding author, RE, upon reasonable request.
ABBREVIATIONS
- 6MWT
- 6-minute walking test
- AS
- Aortic Stenosis
- SAVR
- Surgical Aortic Valve Replacement
- TAVI
- Transcatheter Aortic Valve Implantation
- MET
- Metabolic Equivalent Task
- TEE
- Total Energy Expenditure
- CEES
- Cardiovascular Energy Expenditure Slope
- HR
- Heart Rate
- CO
- Cardiac Output
- SV
- Stroke Volume
- QoL
- Quality of Life
